Znn3bq.jpeg
²é¿´: 1628  |  »Ø¸´: 13
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

project008

Í­³æ (СÓÐÃûÆø)

[ÇóÖú] ר¼ÒÃÇ£¬°ïæ¿´¿´¡°FCTÉó¸åÒâ¼û¡±£¨Major revision£©£¬ÓÐÏ£ÍûÖв»

The review of your manuscript submitted to Food and Chemical Toxicology is complete. The reviewers have made an important number of suggestions that will improve the quality and significance of your manuscript. I encourage you to consider these comments and make an appropriate revision of your manuscript. The reviewers' comments are below. Once you have addressed all comments by the reviewers and your revised manuscript is complete, please submit your revision online by logging onto the Elsevier Editorial System for Food and Chemical Toxicology:

Reviewer #1: Overall, the results detailed in the manuscript make sense as presented. There are grammatical and word choice issues throughout the manuscript that would need to be corrected prior to publication. Major comments concern lack of detail of methods used. Specifically, there is no detail as to how tumor weight and ascites volume were measured. Further, there was no detail for how tumor, and lymph node were collected. It is interesting that there was no discussion of pre-clinical toxicity studies with XXX. All references to XXX describe clinical studies. It might be worth some discussion of pre-clinical toxicity studies to help put the results in the current manuscript into perspective.

Reviewer #2: Minor Revision should be needed
Abstract should be modified, particularly after the objective, author must be included the little more information related methodology.
Introduction
1st paragaraph, line no 12, there are six references, keep any three or two recent references and remaining should be deleted. It may be checked throughout the text
Reference should be checked throughout the text and according the journal format

Reviewer #3:
1 - According to OECD, the treatment must be daily and continous. I suggest that you perform the tests following the OECD international protocols.
2 - You should include in your study a control group that receive only XX, without the xenograft, with the aim to observe abnormalities caused by your test-drug.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

szqi_75

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ö»Òª°´ËûÃǵÄÒªÇóÐ޸쬽ÓÊÕ¾ÍûÓÐÎÊÌâÁË¡£×¨Òµ²»Í¬£¬²»ÖªµÀËûµÄÐÞ¸ÄÒâ¼ûºÃ²»ºÃÐ޸ġ£Ó¦¸ÃûÓÐÎÊÌâ¡£
123
4Â¥2012-07-16 22:36:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 14 ¸ö»Ø´ð

woshi121983

гæ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
project008: ½ð±Ò+1, ¡ïÓаïÖú, ¼Ó·Ö 2012-07-17 08:06:59
ÎÊÌâ²»ÊǺܴ󰡣¬ÈÏÕæ¸ÄÏ£¬»ù±¾¾Í½ÓÊÕÁ˰¡£¡
2Â¥2012-07-16 21:46:21
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

project008

Í­³æ (СÓÐÃûÆø)

Ö÷ÒªÊǵÚÈý¸öÉó¸åÈË£¬ÊÇ·ñÐèÒª²¹³äÊÔÑéÑо¿£¿
3Â¥2012-07-16 22:04:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xiajimu

Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
project008: ½ð±Ò+1, ¡ïÓаïÖú, ¼Ó·Ö 2012-07-17 08:07:12
Ö»ÊÇÐèÒªÐ޸ģ¬±à¼­¿ä´óÁË£¡ºÇºÇ
5Â¥2012-07-16 22:47:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085601³õÊÔ330·ÖÕÒµ÷¼Á +10 Á÷ÐÄÄ̻ưül 2026-04-09 10/500 2026-04-10 08:14 by Sammy2
[¿¼ÑÐ] 080100Á¦Ñ§316Çóµ÷¼Á +5 L_Hairui 2026-04-07 5/250 2026-04-10 05:48 by ССÊ÷2024
[¿¼ÑÐ] »¯Ñ§¹¤³Ìµ÷¼Á289 +41 yangæÃ 2026-04-07 47/2350 2026-04-09 23:23 by wolf97
[¿¼ÑÐ] ²ÄÁÏÀà284µ÷¼Á +32 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-08 37/1850 2026-04-09 23:20 by parmtree
[¿¼ÑÐ] 085404£¬285·ÖÇóµ÷¼Á +12 Þ±Þ±¿¼ÑÐ 2026-04-07 14/700 2026-04-09 23:10 by parmtree
[¿¼ÑÐ] 284Çóµ÷¼Á +7 archer.. 2026-04-09 8/400 2026-04-09 21:30 by bljnqdcc
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£ÖÝ´óѧ 22408 305·ÖÇóµ÷¼Á +3 °²Ð¡Âúzzz 2026-04-08 3/150 2026-04-09 16:16 by wp06
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤×¨Ë¶329 Çóµ÷¼Á +24 ¶îcc 2026-04-06 25/1250 2026-04-09 16:01 by wp06
[¿¼ÑÐ] 22408 270·Ö +9 sanjin020722 2026-04-08 10/500 2026-04-09 14:11 by Ê«Óë×ÔÓÉ
[¿¼ÑÐ] 320·ÖÈ˹¤ÖÇÄܵ÷¼Á +9 Õñ¡ªTZ 2026-04-03 10/500 2026-04-08 19:56 by Õñ¡ªTZ
[¿¼ÑÐ] 22408 266Çóµ÷¼Á +11 masss11222 2026-04-07 14/700 2026-04-08 11:06 by yulian1987
[˶²©¼ÒÔ°] 0856²ÄÁÏ»¯¹¤Çóµ÷¼Á£¬Ò»Ö¾Ô¸211£¬³õÊԳɼ¨349 +4 ½­»´±±Ô 2026-04-05 4/200 2026-04-06 22:44 by chenzhimin
[¿¼ÑÐ] µ÷¼Á +3 Àî¹ã»ð 2026-04-05 3/150 2026-04-05 18:57 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +4 ´Þwj 2026-04-04 5/250 2026-04-05 14:06 by imissbao
[¿¼ÑÐ] 085400µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£© +5 ÐÇÐDz»Õ£ÑÛà¶ 2026-04-03 6/300 2026-04-04 21:50 by hemengdong
[¿¼ÑÐ] ±¾9Ò»Ö¾Ô¸2 0854µÍ·Öר˶286Çóµ÷¼Á +9 âÖÖ111 2026-04-04 9/450 2026-04-04 11:01 by tangruihua
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-04-03 10/500 2026-04-04 09:01 by T¿É¿ÉÎ÷ÀïT
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 15615482637 2026-04-03 3/150 2026-04-03 22:50 by ms629
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©½»Í¨´óѧ²ÄÁϹ¤³Ì×Ü·Ö358 +4 cs0106 2026-04-03 4/200 2026-04-03 13:41 by °ÙÁéͯ888
[¿¼ÑÐ] ÊýÒ»Ó¢Ò»285Çóµ÷¼Á +7 AZMK 2026-04-03 9/450 2026-04-03 13:03 by ms629
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û